Pasithea Therapeutics Corp (KTTA) Stock Price

1.52 ▼ -0.14 (-8.43%)
Open: 1.60 Vol: 306.58K Day's range: 1.45 - 1.6295 May 01, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
KTTA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.56▼ 1.56▼ 1.54▼ 1.66▼ 1.46▲
MA10 1.57▼ 1.58▼ 1.62▼ 1.60▼ 1.34▲
MA20 1.59▼ 1.66▼ 1.68▼ 1.45▲ 1.81▼
MA50 1.68▼ 1.61▼ 1.56▼ 1.30▲ 3.46▼
MA100 1.55▼ 1.50▲ 1.45▲ 1.88▼ 5.93▼
MA200 1.44▲ 1.38▲ 1.45▲ 3.13▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.003▼ -0.025▼ -0.034▼ 0.021▲ 0.126▲
RSI 35.591▼ 38.579▼ 40.547▼ 52.683▲ 37.058▼
STOCH 65.303     25.700     18.297▼ 75.244     31.822    
WILL %R -81.818▼ -92.000▼ -92.308▼ -42.222     -79.795▼
CCI -50.627     -92.932     -117.654▼ 5.712     18.544    
Latest Filters Detected On KTTA
MA $KTTA Price Crossed Below MA(13) Set Alert
▼ GAP $KTTA Open Gap Down %3 Set Alert
▼ GAP $KTTA Open Gap Down %2 Set Alert
Pasithea Therapeutics Corp News
Pasithea Therapeutics Advances Clinical Trial of PAS-004 for Neurofibromatosis and MAPK Pathway Driven Cancers
Tuesday, April 29, 2025 04:12 AM
Here are some of the largest recent moves: (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK ...
Pasithea Therapeutics Announces Acceptance of Abstract for ASCO 2025 Presentation on PAS-004 Clinical Trial Data
Thursday, April 24, 2025 04:14 AM
Here are some of the largest recent moves: (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK ...
Pasithea Therapeutics to Present Updated Data from Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients at the 2025 ASCO Annual Meeting
Thursday, April 24, 2025 04:02 AM
PM CDT at the ASCO Annual MeetingMIAMI, April 24, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing ...
KTTA historical stock data
date open high low close volume
01/05/25 1.60 1.6295 1.45 1.52 306,582
30/04/25 1.66 1.70 1.60 1.66 44,200
29/04/25 1.67 1.71 1.67 1.68 60,838
28/04/25 1.72 1.80 1.5501 1.69 180,966
25/04/25 1.76 1.76 1.60 1.73 170,693
24/04/25 1.64 1.805 1.64 1.72 284,000
23/04/25 1.59 1.63 1.52 1.63 187,379
22/04/25 1.48 1.59 1.40 1.54 229,100
21/04/25 1.41 1.47 1.30 1.43 183,000
17/04/25 1.44 1.4739 1.33 1.38 113,577
Quote Details
52wk Low:0.93
52wk High:7.69
Vol:306.58K
Avg Vol(3m):36M
1Y Chng:-77.14%
1M Chng:+28.81%
Add to Watch List
More Information
Index US Composite
Market Cap. 4.57M